Corrigendum: Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis

Corrigendum: Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis

[This corrects the article DOI: 10.3389/fendo.2023.1214334.].

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in endocrinology (Lausanne) 2024-03, Vol.15, p.1342543-1342543
Hauptverfasser: Zeng, Qingyue, Xu, Jiao, Mu, Xingyu, Shi, Yi, Fan, Hong, Li, Shuangqing
Format: Artikel
Sprache:eng
Schlagworte:
dual agonists
Endocrinology
glucagon-like peptide-1 receptor agonists
incretin based therapy
obesity
tirzepatide
type 2 diabetes
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[This corrects the article DOI: 10.3389/fendo.2023.1214334.].
ISSN:1664-2392
1664-2392
DOI:10.3389/fendo.2024.1342543